chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Grand Mal Seizure 7 days after vaccines, EEG on F/U with focal abnormal activity, MRI normal
11:45: reports felt throat itches and feels heavy; At 12:00 reported to staff;  assessed by staff, BP: 142/90 O2: 98% HR:  99, pt had own epi, self adminstered auto injector; remained alert and oriented x4, remained on RA. 12:10 Transferred to hospital ED.
Approximately 1 minute after receiving HPV vaccine patient had a syncopal episode and went limp onto exam table for approximately 10 seconds. Patient was diaphoretic and responded to gentle stimulation. Assisted patient to sitting position and provided juice. Pt. stated he felt dizzy and like he was dreaming. Observed for 20 minutes without further problems. Dad and patient reassured about event. Instructed Dad to take him to the ER for further syncopal episodes or other complications.
This spontaneous report as received from a certified nurse practitioner refers to a 20 month old male child. On 03-MAR-2014 the patient was inadvertently vaccinated with PNEUMOVAX 23 instead of PREVNAR 13. Lot number, expiry date, route of administration and anatomical location of the vaccination were not reported. The outcome of the event and treatment information were not reported. No adverse effects were reported. Additional information has been requested.
Seen MD Monday AM 1/13/2014. Says in copy of site reaction with red streaks.
Normal symptoms included: itching, swelling, redness, soreness, and fatigue. Also had dizziness and light headedness.
Patient is a 57 y.o. male on warfarin with a history of DVT, type II diabetes mellitus, hypertension, and glaucoma who presents to the emergency department alone for evaluation of COVID suspected. The patient states that he developed a cough yesterday and began feeling weak, short of breath, and dizzy. The patient comes to the ED today because he wants to be tested for COVID-19. Here in the ED, the patient endorses cough and light-headedness. The patient denies any known sick contacts. Of note, the patient is vaccinated and works in the hospital.  He may have had some contacts secondary to that.  He denies any exertional symptoms or chest pain.
Patient reported pain after vaccine was administered on the right arm. The vaccine was given 2.5 inches below shoulder bone. She reports going home and continuing to experience pain and noticing a lump in her inner below. She has set up an appointment to be seen with her provider.
Generalized hives within 2 hours of receiving vaccinations. Swelling around eyes following morning. Treated with po Benadryl. Evaluated by family MD following day. On 8/7 still has a few hives on back.
Information has been received from a 70 year old female consumer with a history of a swelling reaction when administered a tetanus shot, who on 27-MAR-2007 was vaccinated with a dose of Zostavax. There was no concomitant medication. On 28-MAR-2007 the patient experienced a red spot at the injection site. The patient also mentioned that the area was hard and painful when touched. Medical attention was not sought, there were no labs performed. At the time of the report the patient had not recovered. There was no product quality involved. No further information is available.
Hives within 15 minutes, increased heart rate, dizziness Patient was treated with Benadryl 50 mg
Sore arm at injections site, low grade fever, dizziness, muscle aches, headache, severe fatigue lasting for 24 hours
very weak and sleepy; very weak and sleepy; Vomiting; Shivers; had gotten sick; Pain injection site; This is a spontaneous report from a contactable consumer. A 74-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot EL3246, expiry date not reported), intramuscular on 05Jan2021 13:30 at a single dose in the upper left arm for COVID-19 prophylaxis. There were no medical history and concomitant medications. Patient had no prior vaccinations (within 4 weeks). Patient asked if there was any contraindication to getting the second dose. Patient reported having vomiting and shivers the day after receiving the vaccine as well as pain at injection site which was reportedly now resolved. Patient was calling about the Covid-19 vaccine and reported that she received the vaccine this past Tuesday 05Jan2021. She said that she was very sick the next day (06Jan2021). She said that 5 people went with her to get the vaccine and she was the only one who had gotten sick. Patient clarified that she had vomiting throughout the day the next day after receiving the vaccine. She also reported that she had shivers for hours and hours. She said that she had blankets and quilts on her and she could not stop shivering. She said that when she went to the doctor, the doctor thought it was because of the vaccine. Patient wanted to know if she should she take the second shot and if these will happen to her again or not and asked if there are any contraindications. She said that the vomiting started in the morning around 10:00 on 06Jan2021. It lasted a couple of hours until about 13:00 06Jan2021. She said that the shivers were bad, and she had big time shivering and there was nothing she could do to stop the shivering. The shivering lasted from 10:00 06Jan2021 until about 5-6 in the evening 06Jan2021. As the day progressed the pain where they gave her the shot was very bad on 05Jan2021. She said that she had pain at the injection site (pain injection site) on 05Jan2021. She said that it only hurts now if she touches the area. She said that the site previously it hurt without touching it. Patient was very weak and sleepy the next day. She said that she felt very weak and sleepy on 07Jan2021. She said that it lasted throughout the entirety of the day and she fell asleep and felt better today (at the time of the report). She said that today she felt fine. The events did not require emergency room visit but events required physician's office visit. The events were reported as not serious. Therapeutic measures were taken as a result of the events weak and sleepy.  The patient recovered from vomiting on 06Jan2021 13:00, from shivers on 06Jan2021, from weak and sleepy on 07Jan2021. The patient was recovering from pain injection site. The outcome of the event sick was unknown.
husband received only 1st shot of the Moderna COVID19 vaccine Vaccination Provider told the patient that the second dose was not available at the moment; No adverse event; This spontaneous case was reported by a consumer and describes the occurrence of CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (husband received only 1st shot of the Moderna COVID19 vaccine Vaccination Provider told the patient that the second dose was not available at the moment) and NO ADVERSE EVENT (No adverse event) in an adult male patient who received mRNA-1273 (Spikevax) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (husband received only 1st shot of the Moderna COVID19 vaccine Vaccination Provider told the patient that the second dose was not available at the moment) and NO ADVERSE EVENT (No adverse event). At the time of the report, CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (husband received only 1st shot of the Moderna COVID19 vaccine Vaccination Provider told the patient that the second dose was not available at the moment) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (husband received only 1st shot of the Moderna COVID19 vaccine Vaccination Provider told the patient that the second dose was not available at the moment).    It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Caller's husband received only 1st shot of the Moderna COVID19 vaccine  Vaccination Provider told the patient that the second dose was not available at the moment agent provided information from Vaccines org . Concomitant medications were not reported.  No treatment information was provided by the reporter.
3 days after vaccine, felt pins and needles sensation in fingers, feet, and legs.  Some throughout the day.  The following day was the worst of the symptoms.  The pins and needles was somewhat painful.  Overall mainly an annoyance and didn't prevent me from completing any of my daily activities.  While sitting, when feeling another jab I'd need to reposition to try to get comfortable.  These jabs happened at least every 5-10 minutes.  The following day symptoms subsided, more like what was happening on day 3.  By day 6 symptoms were gone.
mild intermittent stomach muscle spasms the following afternoon after receiving the vaccine shot the night before. Same symptoms 48 hours later.
This case was reported by a pharmacist and described the occurrence of swelling injection site in a 50-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, absorbed (DTPa (with small D + P), manufacturer unspecified). Concurrent medical conditions included diabetes. On 223 April 2013 the subject received unspecified dose of DTPa (with small D + P) (.5 ml, unknown, left arm). On 23 April, less than one day after vaccination with DTPa (with small D + P), the subject experienced swelling injection site, injection site pruritus and fever. The subject received the vaccine at a physician's office on 23 April 2013. The subject asked the pharmacist about the side effects of the vaccine. The pharmacist was uncertain if the subject received BOOSTRIX or another Tdap vaccine. At the time of reporting the outcome of the events were unspecified.
after administration of Boostrix, immediate swelling occurred at site of injection. No significant bleeding occurred, patient did report stinging sensation.  Patient stayed in pharmacy for about 10 min for completion of other vaccinations and did not report and worsening or dizziness or difficulties breathing. Patient's doctor was notified of reaction. Swelling was about the size of a quarter and raised about 1/4-1/2 inch.
swelling-pain & stiffness of joints to the degree that pt was unable to work & needed help dressing self; seen by MD 29NOV91 & 30NOV91 dx serum sickness;
after moderna 2nd booster vaccination , the patient felt lightheaded and requested some water. We gave her bottle of water and she was sitting in chair and then she dropped her water bottle and her head fell back and Rph asked if she was ok. She did not respond right away and was just staring and not able to respond so the staff called emergency. When the EMT arrived the patient was beginning to be aware of her surroundings and what was going on and was embarrassed she "fainted". The EMT checked her vitals etc, and she was able to leave on her own.
Swelling in L axilla (L arm injection); numbness and tingling in L arm, including fingers; numbness and tingling in L arm, including fingers; Pain in L axilla; dose_received: 3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 13Nov2021 (Lot number: FH8028) at the age of 39 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL3302), administration date: 19Jan2021, when the patient was 38 years old, for Covid-19 Immunisation; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL0142), administration date: 30Dec2020, when the patient was 38 years old, for Covid-19 Immunisation; Flu, administration date: 06Nov2021, for Immunisation. The following information was reported: IMMUNISATION (non-serious) with onset 13Nov2021, outcome "unknown", described as "dose_received: 3"; LYMPHADENOPATHY (non-serious) with onset 14Nov2021, outcome "not recovered", described as "Swelling in L axilla (L arm injection)"; HYPOAESTHESIA (non-serious), PARAESTHESIA (non-serious) all with onset 14Nov2021, outcome "not recovered" and all described as "numbness and tingling in L arm, including fingers"; AXILLARY PAIN (non-serious) with onset 14Nov2021, outcome "not recovered", described as "Pain in L axilla". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of lymphadenopathy, hypoaesthesia, paraesthesia, axillary pain.  Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. No relevant past drug history. Device Date: 15Nov2021.  Follow-up attempts are completed. No further information is expected.
nurse reports an inc incidence of nodules @ inj site in pts immunized from the same vial of Tetramune (lot# 360918); this was one of three infants to date who devel nodules @ inj site from one particular vial; no treatment was initiated;
Extremely intense migraine attack that hasn't decreased since the vaccine was applied (12 days so far)
This spontaneous report was received from a medical assistant referring to a multiple unspecified patients of unknown age and gender. The patients' pertinent medical history, concurrent conditions, drug reactions/allergies or concomitant medications were not provided. On multiple unspecified dates, the patients were vaccinated with improperly stored PROQUAD Lot #M038860 with an expiration date on 13-MAR-2018, non-valid Lot # M033294 with an expiration date on 13-FEB-2018, Lot # M023931 with an expiration date on 09-NOV-2017 and Lot # M022402 with an expiration date on 01-NOV-2017 (strength, dose and route of administration were not provided) for prophylaxis; all reconstituted with properly stored sterile diluent (manufacturer unknown). The vaccines temperature excursion was between 15°F to 46°F (29°F) for a time frame of 16 hours and 30 minutes. There were previous temperature excursions at 6°F to 14°F for 15 hours and 15°F to 46°F (16.3°F) for 5 hours. A data logger was involved in this report. This is one of two reports received by the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1706USA008290.
Woke up with a hot, swollen red rash on injection site. The rash is around 3 inches in diameter. I have some pain going down my arm. I did not have an adverse reaction until this morning. The only side effect was normal soreness in the injection site until I woke up this morning.   My forehead temp is higher than usual. I temp in each day for work and my temp typically is around 97.4. This morning I temped in at 98.9 and them we temped my injection site and the temp was 101.1.
Pt presents with tender to touch knots on left side of head and right hand (between 4th and 5th digit) and has noticed her neck being stiff but able to have decreased ROM to both sides when turning head to right and left.
I took a home test on June 16, 2022 and I tested positive. I experienced diarrhea, extreme fatigue, head cold, high fever, sneezing, coughing, chills, I was prescribed PAXLOVID for my symptoms.
Received Hib and Prevar in R thigh, 3 hours later had redness of thigh with screaming for at least 3 hours. Another patient in our practice had similar rxn, 2 days later. VAERS report filed today for her also.
Body aches, headache, stiff neck, reddened face, clearing throat often feeling like unable to swallow.
12/26/2021: Event occurred after 2nd vaccine. 58-year-old male with past medical history of Down syndrome, bipolar disorder presents emergency department from a group home after patient was having progressive worsening shortness of breath.  He is currently residing in a group home which multiple residents were tested positive for Covid.  Patient reportedly was tested positive couple days ago and has been having progressive worsening shortness of breath and lethargy. Also had a fever today.Noted to be hypoxic 80% on room air that improved to 96% on 4 L nasal cannula.  CXR clear. Given pt's hy[oxia with positive covid, pt will be admitted for steroids. Given first dose of Decadron 10mg IV here.
3 days after vaccination, required Emergency Exploratory Laparotomy with Ileocolectomy
Information was received on 02-MAR-2017 from a registered nurse regarding a patient (reported as child- age and gender not provided). Medical history, concurrent conditions and concomitant medications were not reported. On unspecified dates "the child" received 2 doses of GARDASIL (dose not specified) and on an unspecified date the child received GARDASIL 9 for the third dose. The nurse wanted to know if they needed to start the 3 dose cycle over with GARDASIL 9 and if the 2 doses of GARDASIL were null and void. No further information was provided. Additional information has been requested.
Tingling throat, itching gums, 15 minutes of uncontrollable hacking cough at onset. Cough subsided but throat still tingles 3 hours after event began
Swollen eyes and tongue upon awaking in AM (about 08:00), self medicated with BENADRYL 25mg cap, CLARITIN 10mg, and ZANTAC 150mg with resolution of symptoms in about 2-4 hours.
Pain and swelling at injection site started 1 day after injection, seen at ER, rxd KEFLEX and advised BENADRYL, worsened for 2 more days before improving.
This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of EXPOSURE DURING PREGNANCY (Exposure during pregnancy) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 3002622A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Exposure during pregnancy). At the time of the report, EXPOSURE DURING PREGNANCY (Exposure during pregnancy) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided. Patient had gestation period of 32 weeks. Most recent FOLLOW-UP information incorporated above includes: On 01-Aug-2021: Translation received.
Developed shingles 3 weeks after first dose.; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 12Apr2021 at 01:30 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 18April2021 at 18:00, the patient developed shingles 3 weeks after first dose. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event shingles and included treatment with antibiotics (Unspecified). Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the event shingles was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
This case was reported by a nurse and described the occurrence of increased thyroid function tests in a 34 year old male patient who received hepatitis B vaccine recombinant (Engerix-B) injection for prophylaxis.  The patient's past medical history included hepatitis C and a positive PPD skin test without active disease.  On 01/08/2003 the patient received his initial immunization with Engerix-B.  Approximately 4 month later, on 05/19/2003, the patient received his second immunization with Engerix-B vaccine.  This represents an inappropriate schedule of vaccine administration, as the recommended schedule for immunization with Engerix B is 0,1, and 6 months.  Approximately six months after receiving the second vaccination with Engerix-B, on 11/24/2003, diagnostic tests revealed elevated thyroid levels.  Thyroid stimulating hormone and thyroxine values were each elevated from baseline.  On 02/12/2004, thyroid levels were further elevated.  The outcome of the events is unknown.
Fever, pain, swelling and redness on injected arm.  Patient took Ibuprofen for the pain and fever.
After my second dose;  I developed inflammatory changes and nodules in  my lymphatic system. I also had nodules in my left axilla then also on my right. I also developed nodules on my neck and also on the submandibular aspect of my jaw.  I went to see my doctor who told me it would take some time to go away but they have not gone away yet.  To this day I still have the nodules in both  axillas and they have not resolved.
Immediately after the vaccine he became nauseous turned white and started sweating profusely. Then his chest felt heavy and he was having a hard time breathing. After that his hand started to go numb and his heart started pounding very hard. At that point the pharmacist came over and put him on the blood pressure machine, his pressure was extremely high! The pharmacist then had him sit for a few minutes and took his blood pressure again and it was still high but he told us we could go home. An hour after being home his heart was still pounding extremely fast and hard so I took him to the emergency room. When we got there they hooked him up to machines and started an IV and reported that he was in atrial fibrillation! They could not normalize his heart for 24 hours while they were trying to get him a hospital bed. There were no hospital beds available after 24 hours so they finally gave him 3 AFib pills which eventually brought his heart into a normal rhythm. He went home shortly after his heart normalized which was approx 26 hours after the initial event.  Nobody in the emergency room had ever seen a young, healthy 20-year-old boy go into AFib after having the vaccine.  He saw a cardiologist three days after the event and that doctor has no idea what happened and he?s never seen anything like this before with a young person with no underlying health issues but believes it had something to do with the vaccine.  This event needed to be reported and investigated ASAP because this was extremely serious and a possible side effect that is extremely rare. It was a very frightening event especially because there is no explanation for why it happened.
Patient was in the office to receive her 5 year old immunizations. Due to patients history at 15 months, Dr. advised patient stay an extra 20 minutes after injections. Nurse who gave injections came and grabbed RN at her desk to come evaluate. Patient initially did not have any reaction but shortly after the 20 minutes, patient stated she did not feel well. Patients face became puffy and two hives appeared- one on her forehead and one by her right eye. Writer grabbed a co-worker to stay in the room with mom and patient and went to speak to Dr. Dr. came into the room and during his evaluation patient started to vomit. EPI PEN and BENADRYL advised to be given. EPI PEN given to patient with positive results. 15 minutes later, 2mL oral BENADRYL given which patient tolerated as well. Patients vitals remained stable during the entire assessment. Patient remained in room another 30 minutes and was cleared to go by Dr.